Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia.

Negative symptoms and cognitive deficits contribute strongly to disability in schizophrenia, and are resistant to existing medications. Recent drug development has targeted enhanced NMDA function by increasing mGluR2/3 signaling. However, the clinical utility of such agents remains uncertain, and markers of brain circuit function are critical for clarifying mechanisms and understanding individual differences in efficacy.

Lexical use in emotional autobiographical narratives of persons with schizophrenia and healthy controls.

Language dysfunction has long been described in schizophrenia and most studies have focused on characteristics of structure and form. This project focuses on the content of language based on autobiographical narratives of five basic emotions. In persons with schizophrenia and healthy controls, we employed a comprehensive automated analysis of lexical use and we identified specific words and semantically or functionally related words derived from dictionaries that occurred significantly more often in narratives of either group.